Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA Read More Advocacy at a Glance STEVEN GROSSMAN 3/27/20 Advocacy at a Glance STEVEN GROSSMAN 3/27/20 FDA Gains $80 Million in Third Pandemic Relief Bill Read More Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides Read More Advocacy at a Glance STEVEN GROSSMAN 3/13/20 Advocacy at a Glance STEVEN GROSSMAN 3/13/20 The Alliance’s March 18 Hill Day Is Still On; New Format to Deliver FDA Funding Message Safely Read More Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Coronavirus Supplemental Likely to Be Considered Quickly Read More Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More Advocacy at a Glance STEVEN GROSSMAN 2/14/20 Advocacy at a Glance STEVEN GROSSMAN 2/14/20 President Proposes Small FY 21 Increase for FDA Read More Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Upcoming Alliance Events Read More Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Upcoming Hill Opportunity for Alliance Members Read More Advocacy at a Glance STEVEN GROSSMAN 1/25/20 Advocacy at a Glance STEVEN GROSSMAN 1/25/20 Notes from the Alliance Meeting with CBER Director, Dr. Peter Marks Read More Advocacy at a Glance STEVEN GROSSMAN 1/17/20 Advocacy at a Glance STEVEN GROSSMAN 1/17/20 The Lull Before FY 21 Appropriations, But Hardly Quiet in Washington Read More Advocacy at a Glance STEVEN GROSSMAN 1/10/20 Advocacy at a Glance STEVEN GROSSMAN 1/10/20 Before Focusing on FY 21 Funding: A Recap of FY 20 Read More Advocacy at a Glance STEVEN GROSSMAN 12/20/19 Advocacy at a Glance STEVEN GROSSMAN 12/20/19 FY 20 Appropriations: Headed to the President for His Signature Read More Advocacy at a Glance STEVEN GROSSMAN 12/16/19 Advocacy at a Glance STEVEN GROSSMAN 12/16/19 Agreement in Principle on All 12 Appropriations Bills. House Slated to Vote Tuesday Read More Advocacy at a Glance STEVEN GROSSMAN 12/8/19 Advocacy at a Glance STEVEN GROSSMAN 12/8/19 The 302(b) Allocations Deal: Fixes Some, But Not All, of the Problems Read More Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Continuing Resolution Extends Funding through December 20 Read More Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Senate Passes First Minibus, Which Includes Ag/FDA Funding Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 3/27/20 Advocacy at a Glance STEVEN GROSSMAN 3/27/20 FDA Gains $80 Million in Third Pandemic Relief Bill Read More
Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides Read More
Advocacy at a Glance STEVEN GROSSMAN 3/13/20 Advocacy at a Glance STEVEN GROSSMAN 3/13/20 The Alliance’s March 18 Hill Day Is Still On; New Format to Deliver FDA Funding Message Safely Read More
Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More
Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Coronavirus Supplemental Likely to Be Considered Quickly Read More
Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More
Advocacy at a Glance STEVEN GROSSMAN 2/14/20 Advocacy at a Glance STEVEN GROSSMAN 2/14/20 President Proposes Small FY 21 Increase for FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Upcoming Alliance Events Read More
Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Upcoming Hill Opportunity for Alliance Members Read More
Advocacy at a Glance STEVEN GROSSMAN 1/25/20 Advocacy at a Glance STEVEN GROSSMAN 1/25/20 Notes from the Alliance Meeting with CBER Director, Dr. Peter Marks Read More
Advocacy at a Glance STEVEN GROSSMAN 1/17/20 Advocacy at a Glance STEVEN GROSSMAN 1/17/20 The Lull Before FY 21 Appropriations, But Hardly Quiet in Washington Read More
Advocacy at a Glance STEVEN GROSSMAN 1/10/20 Advocacy at a Glance STEVEN GROSSMAN 1/10/20 Before Focusing on FY 21 Funding: A Recap of FY 20 Read More
Advocacy at a Glance STEVEN GROSSMAN 12/20/19 Advocacy at a Glance STEVEN GROSSMAN 12/20/19 FY 20 Appropriations: Headed to the President for His Signature Read More
Advocacy at a Glance STEVEN GROSSMAN 12/16/19 Advocacy at a Glance STEVEN GROSSMAN 12/16/19 Agreement in Principle on All 12 Appropriations Bills. House Slated to Vote Tuesday Read More
Advocacy at a Glance STEVEN GROSSMAN 12/8/19 Advocacy at a Glance STEVEN GROSSMAN 12/8/19 The 302(b) Allocations Deal: Fixes Some, But Not All, of the Problems Read More
Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Continuing Resolution Extends Funding through December 20 Read More
Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More
Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More
Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Senate Passes First Minibus, Which Includes Ag/FDA Funding Read More
